6533b7defe1ef96bd1276990

RESEARCH PRODUCT

Phytochemical-rich extracts of Helianthemum lippii possess antimicrobial, anticancer, and anti-biofilm activities

Fabiana PlesciaFabio VenturellaAntonella D’anneoValentina CataniaMaria Letizia GarganoGiulia PolitoDomenico SchillaciAntonio Palumbo-piccionelloMarianna LauricellaGiuseppe VenturellaDemetrio Raffa

subject

HPLC-UV-ESI-QTOF-MS analysielianthemum lippiCytotoxic effectAntibiofilm activitySettore BIO/10 - BiochimicaSettore BIO/02 - Botanica SistematicaSettore BIO/14 - FarmacologiaPlant ScienceAntimicrobial activitySettore BIO/19 - Microbiologia GeneraleSettore CHIM/08 - Chimica FarmaceuticaEcology Evolution Behavior and Systematics

description

Helianthemum lippii is a perennial shrubby plant growing in the sandy environments of Italy, Mediterranean countries of North Africa and Middle East. H. lippii is used in traditional medicine but there are very few reports referring to the phytochemical characterization, the ethnopharmacology, and the biological activity of H. lippii. The goal of this study was todetermine the phytochemical composition of different H. lippii extracts, cold (CME) and hot (HME) methanol, cold (CPEE) and hot (HPEE) petroleum ether, as well as to evaluate their anticancer and antimicrobial activities and biofilm formation reduction. Fifty-fours phytocompounds have been determined by HPLC-UV-ESI-QTOF-MS analysis. All the four extracts reduced the viability of human MDA-MB231 and HCT116 cells, being cold and hot methanol extracts the most effective. The antimicrobial activity against S. aureus, P. aeruginosa, E. faecalis, E. coli, C. albicans was also evaluated. Data showed the greater susceptibility of S. aureus to hot methanolic extract. Concerning antifungal activity, C. albicans resulted more susceptible to petroleum ether. Moreover, some of the samples exhibited a good antibiofilm activity both on immature and on mature biofilms. The four extracts showed interesting antimicrobial and cytotoxic activities and can be considered good candidates for new therapeutic applications

https://doi.org/10.1080/11263504.2022.2048274